Q1 2025 Tarsons Products Ltd Earnings Call Transcript
Key Points
- Tarsons Products Ltd (BOM:543399) reported a 3.6% increase in stand-alone revenues for Q1 FY25, reaching INR64.9 crores compared to INR62.6 crores in Q1 FY24.
- The company has seen signs of recovery in the plastic labware industry with increased order inquiries in both domestic and international markets.
- Tarsons Products Ltd (BOM:543399) has been actively participating in large RFQs and overseas tenders, which have shown encouraging initial inquiries from new prospects.
- The new Panchla facility is expected to commence operations by H2 of this financial year, which will enhance production capacity and introduce new product categories.
- The acquisition of Nerbe plus, a Germany-based plastic labware distribution company, is expected to deepen Tarsons' presence in key European geographies and bring new customers, revenue growth, and increased profitability.
- Despite the revenue growth, the stand-alone adjusted EBITDA for Q1 FY25 stood at INR20 crores, down from INR24.1 crores in Q1 FY24.
- Reported EBITDA margins in Q1 FY25 were impacted by a change in product mix, increased employee expenses, and a provision of INR3 crores for machinery damaged during transit.
- The consolidated profit after tax for Q1 FY25 was INR4 crores with a PAT margin of 4.7%, indicating a decline compared to previous periods.
- The commissioning of the new Panchla facility has been delayed due to machinery damage during transit, affecting the timeline for capacity utilization.
- The inclusion of Nerbe plus, which has lower margins compared to Tarsons' India manufacturing business, may result in lower consolidated margins going forward.
Ladies and gentlemen, good day, and welcome to the Tarsons Products Limited Q1 FY25 earnings conference Call hosted by AMBIT Capital. (Operator Instructions) Please note that this conference is being recorded.
I now hand the conference over to Mr. Jaiveer Shekhawat from AMBIT Capital. Thank you, and over to you, Mr. Shekhawat.
Thank you, Via. Good afternoon, everyone. On behalf of AMBIT Capital, I welcome you all to Tarsons Products' Q1 FY25 earnings conference call. From the management today, we have Mr. Aryan Sehgal, Promoter and Whole-Time Director; and Mr. Santosh Agarwal, the Chief Financial Officer.
Now without further ado, I would request Aryan to start with his opening remarks, post which we can open the floor for question and answer. Thanks, and over to you, Aryan.
Good afternoon, everyone, and a very warm welcome to all on our Q1 FY25 earnings conference call for Tarsons.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
